PRENTISS CHRISTOPHER B (Chief Accounting Officer) received a stock award from ADAMAS PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/24/2021ACC: 0001328143-21-000092
Officer· Chief Accounting Officer
Since Dec 2018
-232.52K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
18.75K acquired · 251.27K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+18.75K
Price / share
—
Trade value
—
% of position
12.9%
11/24/2021
145.02K→163.77K
Common Stock
Direct
Shares
−163.77K
Price / share
—
Trade value
—
% of position
New position
11/24/2021
163.77K→0.00
Total
Net shares
−145.02K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/24/2021 | A · Award | +18.75K | — | — | 12.9% | 145.02K | 163.77K |
| Common Stock Direct | 11/24/2021 | U · U | −163.77K | — | — | New position | 163.77K | 0.00 |
| Total | −145.02K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
37.50K shares
Shares
−37.50K
Strike price
6.81
Held after
0.00
Exercisable
—
11/24/2021
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
4.7
Held after
0.00
Exercisable
—
11/24/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock37.50K shares | 11/24/2021 | D · Disposition | −37.50K | 6.81 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock50K shares | 11/24/2021 | D · Disposition | −50K | 4.7 | — | 0.00 |